Low-Frequency Bladder Vibration Beneficial for UTI in Spinal Cord Injury
By Elana Gotkine HealthDay Reporter
THURSDAY, March 6, 2025 -- Applying low-frequency bladder vibration (LFBV) to patients with spinal cord injury (SCI)/neurogenic bladder who developed urinary tract infections (UTIs) during rehabilitation is associated with a reduction in urinary leukocytes and urinary bacteria on day 10, according to a study recently published in International Urology and Nephrology.
Yingying Zhang, from The First Affiliated Hospital of Soochow University in Suzhou, China, and colleagues conducted a single-blind randomized controlled trial involving patients who developed UTIs while rehabilitating from SCI. Participants were randomly assigned to a control or intervention group (44 and 43 patients, respectively); the intervention group received LFBV twice daily for 10 days.
The researchers found that the intervention group had significantly higher urinary leukocytes on day 2 and significantly lower urinary leukocytes and urinary bacteria on day 10 compared with the control group. The intervention group had significantly lower urinary leukocytes and postvoid residual volume, fewer signs and symptoms of UTI, and significantly higher urine volume four weeks after LFBV. No significant change was seen in urinary red blood cells or occult blood due to LFBV.
"The improvements were sustained up to four weeks after the intervention," the authors write. "It may be helpful to incorporate bladder vibration into the standard rehabilitation protocol for SCI patients."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted March 2025
Read this next
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.